0 Items
Select Page

Toscana Virus

Toscana virus (TOSV) or Sandfly fever Naples phlebovirus (SFNV) is a member of the genus Phlebovirus of the family Bunyaviridae. TOSV is an arthropod-borne virus that is transmitted by sandfly of the Phlebotomus species, including Phlebotomus perniciosus and Phlebotomus perfiliewi. The virus is a significant cause of aseptic meningitis in endemic areas and the disease caused by TOSV is prevalent during the summer months when the sandfly is most abundant. Although initially isolated in Italy, Toscana virus is now geographical widespread throughout the Mediterranean region including Italy, France, Spain, Portugal, Greece, Croatia, Cyprus and Turkey.

Toscana Virus Background

Toscana virus (TOSV) or Sandfly fever Naples phlebovirus (SFNV) is a member of the genus Phlebovirus of the family Bunyaviridae. TOSV is an enveloped, single-stranded, negative-sense RNA virus. The viral genome is segmented, having three segments that are referred to as large (L), medium (M) and small (S). These segments encode the viral RNA-dependent RNA polymerase, envelope glycoproteins, nucleoproteins and non-structural proteins. Two genotypes of TOSV have been identified, which are referred to as lineage A and lineage B. However, some reports suggest that there may be additional lineages of the virus in circulation (Cusi, MG).

TOSV is an arthropod-borne virus that is transmitted by sandfly of the Phlebotomus species, including Phlebotomus perniciosus and Phlebotomus perfiliewi. Since the virus was first isolated from sandfly in 1971, no bird or small mammal reservoir has been reliably identified, suggesting that infected sandfly may act as vector and reservoir for TOSV. The disease caused by TOSV is prevalent during the summer months when the sandfly is most abundant (Charrel, RN). Although initially isolated in Italy, Toscana virus is now geographical widespread throughout the Mediterranean region including Italy, France, Spain, Portugal, Greece, Croatia, Cyprus and Turkey.

TOSV is a serotype of Sandfly-fever viruses, with a neuroinvasive nature. The virus causes a febrile illness called pappataci-fever (or Sandfly-fever) but can also cause neurological disease including aseptic meningitis, encephalitis or meningoencephalitis. In many cases, TOSV infection is asymptomatic or presents as a self-limiting febrile illness. However, some patients develop a range of neurological symptoms which include meningitis like symptoms, headache, neck-stiffness, nausea, vomiting, myalgia and weakness. Other neurological symptoms have been reported including deafness, speech disorders and paresis.

In Europe, TOSV represents an important emerging pathogen that has the potential to spread to countries outside the Mediterranean. The virus is a significant cause of aseptic meningitis in endemic areas. Currently, there is no antiviral therapy for the treatment of symptomatic cases of TOSV, and no licensed prophylactic vaccine to prevent TOSV infection. Diagnosis of TOSV in humans is achieved using molecular methods to detect the virus or serological methods to measure Toscana virus specific IgM levels in infected patients.

 

References

Cusi MG, Savellini GG, Zanelli G.2010.Toscana virus epidemiology: from Italy to beyond. Open Virol J. 2010 Apr 22;4:22-8.

Charrel RN, Bichaud L, de Lamballerie X.2012.Emergence of Toscana virus in the Mediterranean area. World J Virol. 2012 Oct 12;1(5):135-41.

Toscana Virus Antigens

The Native Antigen Company have developed recombinant Toscana proteins in our mammalian cell expression system. These antigens are suitable for use in assay development, vaccine research and as antigens for the preparation of antibodies.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Using Adenoviruses to Fight Cancer

In the second of a 2-part series, we discuss how adenoviruses are being developed to treat cancer and some of the hurdles these platforms face from our own immune systems. Curing cancer is one of the biggest challenges of the 21st century. Our knowledge of cancer’s...

New Immunofluorescence Data for our CMV, Yellow Fever and Ebola Antibodies

In September 2018 The Native Antigen Company and Virology Research Services (VRS) were awarded the Medical Research Council (Proximity to Discovery Award for Knowledge Exchange) to test a large panel of our viral antibodies in immunofluorescence applications. This...

Why are ticks such good vectors of pathogens?

In this blog, Professor Patricia Nuttall discusses what makes ticks such effective vectors of pathogens and how we might prevent the spread of tick-borne diseases. About Patrica Nuttall Pat Nuttall is Emeritus Professor of Arbovirology in the Department of Zoology,...

Dengue in 2019

What's going on with dengue? Dengue virus (DENV) has been in the news a lot recently. The number of reported cases continues to climb year-on-year and 2019 has been especially bad. Rio de Janeiro has seen a 45% increase in dengue cases in the first two months of 2019...

Zika Prevalence in Suriname – an insight into assay cross-reactivity

A recent study published by Langerak et al tested for the seroprevalence of Zika virus in Suriname populations and evaluated the comparative effectiveness of using a commercial ELISA and a standard Virus Neutralisation Assay. Here we discuss the study, its results,...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

2 + 15 =

Live Customer Feedback